Correlation between serum D-Dimer level and volume in acute ischemic stroke

Journal of Korean Neurosurgical Society

Volumn 50, Issue 2, 2011, Pages 89-94

  Park, Young Woo ^a   Koh, Eun Jeong ^a   Choi, Ha Young ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Acute ischemic stroke; D dimer; Volume

Indexed keywords

ALTEPLASE; ARGATROBAN; BLOOD CLOTTING INHIBITOR; D DIMER;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN EMBOLISM; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTION; PROTEIN BLOOD LEVEL; RANKIN SCALE;

EID: 80053225382     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2011.50.2.89     Document Type: Article

References (46)

1. Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al.: Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53: 126-131, 1999
2. Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi D'Eril G, et al.: Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 162: 2589-2593, 2002
3. Baird AE, Lövblad KO, Dashe JF, Connor A, Burzynski C, Schlaug G, et al.: Clinical correlations of diffusion and perfusion lesion volumes in acute ischemic stroke. Cerebrovasc Dis 10: 441-448, 2000
4. Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ: D-dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays. Stroke 37: 1113-1115, 2006
5. Barber M, Langhorne P, Rumley A, Lowe GDO, Stott DJ: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 35: 1421-1425, 2004
6. Berge E, Friis P, Sandset PM: Hemostatic activation in acute ischemic stroke. Thromb Res 101: 13-21, 2001
7. Birschel P, Ellul J, Barer D: Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis 17: 242-252, 2004
8. Dastidar P, Heinonen T, Ahonen JP, Jehkonen M, Molnár G: Volumetric measurements of right cerebral hemisphere infarction: use of a semiautomatic MRI segmentation technique. Comput Biol Med 30: 41-54, 2000
9. Dunn KL, Wolf JP, Dorfman DM, Fitzpatrick P, Baker JL, Goldhaber SZ: Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol 40: 1475-1478, 2002
10. Feinberg WM, Bruck DC, Ring ME, Corrigan JJ Jr: Hemostatic markers in acute stroke. Stroke 20: 592-597, 1989
11. Flaherty ML, Woo D, Kissela B, Jauch E, Pancioli A, Carrozzella J, et al.: Combined IV and intraarterial thrombolysis for acute ischemic stroke. Neurology 64: 386-388, 2005
12. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282: 2003-2011, 1999
13. Gibler WB, Blomkalns AL, Collins SP: Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide. Rev Cardiovasc Med 4 Suppl 4: S47-S55, 2003
14. Haapaniemi E, Soinne L, Syrjälä M, Kaste M, Tatlisumak T: Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke. Acta Neurol Scand 110: 242-247, 2004
15. Haapaniemi E, Tatlisumak T: Is D-dimer helpful in evaluating stroke patients? A systematic review. Acta Neurol Scand 119: 141-150, 2009
16. Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Helber U, Kazmaier S, et al.: Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation 98: 2527-2533, 1998
17. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35: 904-911, 2004
18. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR: Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Stroke 37: 2508-2513, 2006
19. Kelly PJ, Morrow JD, Ning M, Koroshetz W, Lo EH, Terry E, et al.: Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation or Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39: 100-104, 2008
20. Kobayashi S, Tazaki Y: Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin Thromb Hemost 23: 531-534, 1997
21. Koch HJ, Horn M, Bogdahn U, Ickenstein GW: The relationship between plasma D-dimer concentrations and acute ischemic stroke subtypes. J Stroke Cerebrovasc Dis 14: 75-79, 2005
22. Laskowitz DT, Blessing R, Floyd J, White WD, Lynch JR: Panel of biomarkers predicts stroke. Ann N Y Acad Sci 1053: 30, 2005
23. Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC: Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 40: 77-85, 2009
24. Lee KY, Kim DI, Kim SH, Lee SI, Chung HW, Shim YW, et al.: Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 25: 1470-1475, 2004
25. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 30: 2598-2605, 1999
26. Lip GY, Blann AD, Farooqi IS, Zarifis J, Sagar G, Beevers DG: Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: the West Birmingham Stroke Project. Blood Coagul Fibrinolysis 13: 339-347, 2002
27. Lövblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, et al.: Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 42: 164-170, 1997
28. Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT: Novel diagnostic test for acute stroke. Stroke 35: 57-63, 2004
29. Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, et al.: Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39: 2280-2287, 2008
30. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 30: 981-985, 1999
31. Park SY, Kim MH, Kang SY, Suh JT, Lee WI: Inflammatory marker expression and its implication in Korean ischemic stroke patients. Korean J Lab Med 27: 197-204, 2007
32. Penttilä K, Koukkunen H, Halinen M, Rantanen T, Pyörälä K, Punnonen K, et al.: Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. Clin Biochem 35: 647-653, 2002
33. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D, et al.: Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 353: 190-195, 1999
34. Reganon E, Vila V, Martínez-Sales V, Vaya A, Lago A, Alonso P, et al.: Association between inflammation and hemostatic markers in atherothrombotic stroke. Thromb Res 112: 217-221, 2003
35. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, et al.: Early biomarkers of stroke. Clin Chem 49: 1733-1739, 2003
36. Rosamond W, Flegal K, Friday G: Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115: e69-e171, 2007
37. Rundek T, Sacco RL: Risk factor management to prevent first stroke. Neurol Clin 26: 1007-1045, ix, 2008
38. Saposnik G, Di Legge S, Webster F, Hachinski V: Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 65: 1169-1174, 2005
39. Sibon I, Rouanet F, Meissner W, Orgogozo JM: Use of the Triage Stroke Panel in a neurologic emergency service. Am J Emerg Med 27: 558-562, 2009
40. Skoloudík D, Bar M, Sanák D, Bardon P, Roubec M, Langová K, et al.: D-dimers increase in acute ischemic stroke patients with the large artery occlusion, but do not depend on the time of artery recanalization. J Thromb Thrombolysis 29: 477-482, 2010
41. Skoloudík D, Bar M, Zapletalová O, Langová K, Herzig R, Kanovský P: D-dimer levels in acute stroke patients. Cesk Slov Neurol N 103: 375-379, 2007
42. Takagi S, Shinohara Y: Internal carotid occlusion: volume of cerebral infarction, clinical findings, and prognosis. Stroke 12: 835-839, 1981
43. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587, 1995
44. Tombul T, Atbas C, Anlar O: Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. J Clin Neurosci 12: 429-434, 2005
45. Whiteley W, Tseng MC, Sandercock P: Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke 39: 2902-2909, 2008
46. Zaidat OO, Suarez JI, Santillan C, Sunshine JL, Tarr RW, Paras VH, et al.: Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 33: 1821-1826, 2002